Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue.

Autor: Finke, C, Schlichting, J, Papazoglou, S, Scheel, M, Freing, A, Soemmer, C, Pech, LM, Pajkert, A, Pfüller, C, Wuerfel, JT, Ploner, CJ, Paul, F, Brandt, AU

Publikováno v: Multiple Sclerosis Journal; Jun2015, Vol. 21 Issue 7, p925-934, 10p, 3 Charts, 2 Graphs

Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial.

Autor: Uccelli A; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, and Center of Excellence for Biomedical Research, University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Electronic address: auccelli@neurologia.unige.it., Laroni A; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, and Center of Excellence for Biomedical Research, University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Ali R; Department of Brain Sciences, Imperial College London, London, UK., Battaglia MA; Department of Life Sciences, University of Siena, Italy; Italian Multiple Sclerosis Foundation, Genoa, Italy., Blinkenberg M; Danish Multiple Sclerosis Centre, Department of Neurology, University of Copenhagen and Rigshospitalet, Copenhagen, Denmark., Brundin L; Department of Clinical Neuroscience, Karolinska Institutet, and Division of Neurology, Karolinska University Hospital, Stockholm, Sweden., Clanet M; Department of Neurology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France., Fernandez O; Department of Neurology, Instituto de Investigación Biomédica de Málaga, Hospital Regional Universitario, Málaga, Spain., Marriot J; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada., Muraro P; Department of Brain Sciences, Imperial College London, London, UK., Nabavi SM; Department of Brain and Cognitive Sciences, Cell Science Research Centre and Regenerative Medicine Department, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research, Tehran, Iran., Oliveri RS; Cell Therapy Unit, Department of Clinical Immunology, University of Copenhagen and Rigshospitalet, Copenhagen, Denmark., Radue E; Medical Image Analysis Centre and Department of Biomedical Engineering, University of Basel, Basel, Switzerland., Ramo Tello C; Multiple Sclerosis Unit, Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Schiavetti I; Department of Health Sciences, University of Genoa, Genoa, Italy., Sellner J; Department of Neurology, Christian Doppler Medical Centre, Paracelsus Medical University, Salzburg, Austria; Department of Neurology, Landesklinikum Mistelbach-Gänserndorf, Mistelbach, Austria., Sorensen PS; Danish Multiple Sclerosis Centre, Department of Neurology, University of Copenhagen and Rigshospitalet, Copenhagen, Denmark., Sormani MP; Department of Health Sciences, University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Wuerfel JT; Medical Image Analysis Centre and Department of Biomedical Engineering, University of Basel, Basel, Switzerland., Freedman MS; Department of Medicine, University of Ottawa, Ottawa, ON, Canada; The Ottawa Hospital Research Institute, Ottawa, ON, Canada. Electronic address: mfreedman@toh.ca.

Publikováno v: The Lancet. Neurology [Lancet Neurol] 2021 Nov; Vol. 20 (11), pp. 917-929.

Inflammation-induced brain endothelial activation leads to uptake of electrostatically stabilized iron oxide nanoparticles via sulfated glycosaminoglycans.

Autor: Berndt D; Institute for Medical Immunology, Charité-Universtitätsmedizin Berlin, Berlin, Germany; Cluster of Excellence NeuroCure and Department of Neurology and Experimental and Clinical Research Center, Universitätsmedizin Berlin, Berlin, Germany., Millward JM; Institute for Medical Immunology, Charité-Universtitätsmedizin Berlin, Berlin, Germany; Experimental and clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité Universitätsmedizin, Berlin., Schnorr J; Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Taupitz M; Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Stangl V; Medizinische Klinik mit Schwerpunkt Kardiologie und Angiologie, Charité, Universitätsmedizin Berlin, Berlin, Germany., Paul F; Experimental and clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité Universitätsmedizin, Berlin; Cluster of Excellence NeuroCure and Department of Neurology and Experimental and Clinical Research Center, Universitätsmedizin Berlin, Berlin, Germany., Wagner S; Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Wuerfel JT; Cluster of Excellence NeuroCure and Department of Neurology and Experimental and Clinical Research Center, Universitätsmedizin Berlin, Berlin, Germany., Sack I; Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Ludwig A; Medizinische Klinik mit Schwerpunkt Kardiologie und Angiologie, Charité, Universitätsmedizin Berlin, Berlin, Germany., Infante-Duarte C; Institute for Medical Immunology, Charité-Universtitätsmedizin Berlin, Berlin, Germany; Experimental and clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité Universitätsmedizin, Berlin. Electronic address: carmen.infante@charite.de.

Publikováno v: Nanomedicine : nanotechnology, biology, and medicine [Nanomedicine] 2017 May; Vol. 13 (4), pp. 1411-1421. Date of Electronic Publication: 2017 Jan 25.

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.

Autor: Kremer S; ICube (UMR 7357, UdS, Centre National de la Recherche Scientifique), Fédération de médecine translationelle de Strasbourg, Université de Strasbourg, Strasbourg, France2Department of Radiology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Renard F; Centre National de la Recherche Scientifique, Grenoble Image Parole Signal Automatique, Grenoble, France., Achard S; Centre National de la Recherche Scientifique, Grenoble Image Parole Signal Automatique, Grenoble, France., Lana-Peixoto MA; CIEM MS Research Center, University of Minas Gerais, Minas Gerais, Brazil., Palace J; Department of Neurology, Oxford University Hospital Trust, Oxford, England., Asgari N; Department of Neurobiology, Institute of Molecular Medicine, University of Southern Denmark, Odense7Department of Neurology, Vejle Hospital, Vejle, Denmark., Klawiter EC; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston., Tenembaum SN; Department of Neurology and Neurophysiology, National Pediatric Hospital Dr Juan P. Garrahan, Buenos Aires, Argentina., Banwell B; Department of Neurology, University of Pennsylvania, Philadelphia11Division of Child Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Greenberg BM; Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas13Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas., Bennett JL; Department of Neurology, University of Colorado Denver, Aurora15Department of Ophthalmology, University of Colorado Denver, Aurora., Levy M; Department of Neurology, Johns Hopkins University, Baltimore, Maryland., Villoslada P; Institute of Biomedical Research August Pi Sunyer-Hospital Clínic de Barcelona, Barcelona, Spain., Saiz A; Institute of Biomedical Research August Pi Sunyer-Hospital Clínic de Barcelona, Barcelona, Spain., Fujihara K; Department of Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan., Chan KH; University Department of Medicine, Research Center of Heart, Brain, Hormone and Healthy Aging, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China., Schippling S; Neuroimmunology and Multiple Sclerosis Research Section, University Hospital Zurich, Zurich, Switzerland21Department of Neurology, University Hospital Zurich, Zurich, Switzerland22Neuroscience Center Zurich, Federal Technical High School Zurich, Zurich, S., Paul F; NeuroCure Clinical Research Center, Charité University Medicine, Berlin, Germany25Clinical and Experimental Multiple Sclerosis Research Center, Charité University Medicine, Berlin, Germany26Department of Neurology, Charité University Medicine, Berlin, Ger., Kim HJ; Department of Neurology, Research Institute, Goyang, Korea28Hospital of National Cancer Center, Goyang, Korea., de Seze J; Neurology Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France30Clinical Investigation Center (INSERM 1434), Hôpitaux Universitaires de Strasbourg, Strasbourg, France31UMR INSERM 1119 and Fédération de médecine translationelle, Strasbourg., Wuerfel JT; NeuroCure Clinical Research Center, Charité University Medicine, Berlin, Germany25Clinical and Experimental Multiple Sclerosis Research Center, Charité University Medicine, Berlin, Germany26Department of Neurology, Charité University Medicine, Berlin, Ger., Cabre P; CHU de Fort de France, Martinique., Marignier R; CHU, Lyon, France., Tedder T; Duke University School of Medicine, Durham, North Carolina., van Pelt D; Erasmus MC, Rotterdam, the Netherlands., Broadley S; Griffith University, Southport, Queensland, Australia., Chitnis T; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston., Wingerchuk D; Mayo Clinic, Scottsdale, Arizona., Pandit L; Nitte University, Mangalore, Karnataka, India., Leite MI; Department of Neurology, Oxford University Hospital Trust, Oxford, England., Apiwattanakul M; Prasat Neurological Institute, Bangkok, Thailand., Kleiter I; Ruhr University, Bochum, Germany., Prayoonwiwat N; Siriraj Hospital, Mahidol University, Bangkok, Thailand., Han M; Stanford University School of Medicine, Palo Alto, California., Hellwig K; St Josef Hospital, Bochum, Germany., van Herle K; The GJCF, San Diego, California., John G; Mount Sinai Hospital, New York, New York., Hooper DC; Thomas Jefferson University, Philadelphia, Pennsylvania., Nakashima I; Department of Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan., Sato D; Department of Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan., Yeaman MR; University of California, Los Angeles., Waubant E; University of California, San Francisco., Zamvil S; University of California, San Francisco., Stüve O; Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas13Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas., Aktas O; University of Düsseldorf, Düsseldorf, Germany., Smith TJ; University of Michigan, Ann Arbor., Jacob A; Walton Center, Liverpool, England., O'Connor K; Yale University School of Medicine, New Haven, Connecticut.

Publikováno v: JAMA neurology [JAMA Neurol] 2015 Jul; Vol. 72 (7), pp. 815-22.

Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations.

Autor: Zimmermann H; NeuroCure Clinical Research Centre and Experimental and Clinical Research Centre, Charité-Universitätsmedizin Berlin and Max Delbrueck Centre for Molecular Medicine, Berlin, Germany., Freing A, Kaufhold F, Gaede G, Bohn E, Bock M, Oberwahrenbrock T, Young KL, Dörr J, Wuerfel JT, Schippling S, Paul F, Brandt AU

Publikováno v: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2013 Apr; Vol. 19 (4), pp. 443-50. Date of Electronic Publication: 2012 Aug 30.